Papillary lesions of the breast discovered on percutaneous large core and vacuum-assisted biopsies: reliability of clinical and pathological parameters in identifying benign lesions

被引:50
作者
Ashkenazi, Itamar
Ferrer, Karen
Sekosan, Marin
Marcus, Elizabeth
Bork, Jeff
Aiti, Tamer
Lavy, Ron
Zaren, Howard A.
机构
[1] John H Stronger Jr Hosp Cook Cty, Minor Based Community Clin Oncol Program, Chicago, IL 60612 USA
[2] Dept Pathol, Chicago, IL 60612 USA
[3] Dept Surg, Chicago, IL 60612 USA
关键词
papillary lesion; breast core biopsy; percutaneous breast biopsy; papilloma;
D O I
10.1016/j.amjsurg.2006.11.028
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: A review of the literature reveals conflicting evidence on whether core biopsy, complemented with concordant imaging, is sufficient in differentiating benign from malignant papillary lesions. Our objective was to evaluate whether in our patient population, commonly used clinical and pathological parameters could predict benignity, thus eliminating the need to proceed with excision. Methods: A retrospective review of clinical variables and pathologic slides of 39 patients in whom both core biopsy and excisional biopsy were available for evaluation. Results: Excision revealed malignancy in 44%. Risk factors for malignancy, palpability, size, or Breast Imaging Reporting and Data System (American College of Radiology, Reston, VA) did not help differentiate benign from malignant disease. Younger age and core biopsies revealing minimal or no atypia were predictive of benignity. However, 4 (25%) of 20 patients whose core biopsies were classified as probably benign were found to have malignancy on excision. Conclusions: Caution should be used in recommending nonoperative management after a core biopsy revealing a papillary lesion. (C) 2007 Excerpta Medica Inc. All rights reserved.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 26 条
  • [1] Papillary lesions of the breast with and without atypical ductal hyperplasia - Can we accurately predict benign behavior from core needle biopsy?
    Agoff, SN
    Lawton, TJ
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (03) : 440 - 443
  • [2] [Anonymous], BREAST IM REP DAT SY
  • [3] Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast
    Carder, PJ
    Garvican, J
    Haigh, I
    Liston, JC
    [J]. HISTOPATHOLOGY, 2005, 46 (03) : 320 - 327
  • [4] Association of breast cancer with papillary lesions identified at percutaneous image-guided breast biopsy
    Gendler, LS
    Feldman, SM
    Balassanian, R
    Riker, MA
    Frencher, SK
    Whelan, DB
    Anne, S
    Gross, JD
    Cohen, JM
    Boolbol, SK
    [J]. AMERICAN JOURNAL OF SURGERY, 2004, 188 (04) : 365 - 370
  • [5] Myoepithelial cell staining patterns of papillary breast lesions - From intraductal papillomas to invasive papillary carcinomas
    Hill, CB
    Yeh, IT
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (01) : 36 - 44
  • [6] IOFFE OB, 2000, MODERN PATHOL, V13, pA23
  • [7] Irfan Kashif, 2002, Breast J, V8, P230, DOI 10.1046/j.1524-4741.2002.08408.x
  • [8] Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy
    Ivan, D
    Selinko, V
    Sahin, AA
    Sneige, N
    Middleton, LP
    [J]. MODERN PATHOLOGY, 2004, 17 (02) : 165 - 171
  • [9] Assessing breast cancer risk - Genetic factors are not the whole story
    Korde, LA
    Calzone, KA
    Zujewski, J
    [J]. POSTGRADUATE MEDICINE, 2004, 116 (04) : 6 - +
  • [10] Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: Frequency of mammographic change and false-negative rate
    Lee, CH
    Philpotts, LE
    Horvath, LJ
    Tocino, I
    [J]. RADIOLOGY, 1999, 212 (01) : 189 - 194